Literature DB >> 11856330

Anti-(Raf-1) RNA aptamers that inhibit Ras-induced Raf-1 activation.

Michiko Kimoto1, Mikako Shirouzu, Shin Mizutani, Hiroshi Koide, Yoshito Kaziro, Ichiro Hirao, Shigeyuki Yokoyama.   

Abstract

RNA aptamers with affinity for the Ras-binding domain (RBD) of Raf-1 were isolated from a degenerate pool by in vitro selection. These aptamers efficiently inhibited the Ras interaction with the Raf-1 RBD, and also inhibited Ras-induced Raf-1 activation in a cell-free system. The RNA aptamer with the most potent inhibitory effect specifically inhibited the Ras-Raf-1 interaction and had no affinity for the RBD of the RGL protein, a homolog of the Ral GDP dissociation stimulator. Although the aptamer was capable of binding to the B-Raf RBD, the RNA did not inhibit the interaction between Ras and the B-Raf RBD. Enzymatic and chemical probing experiments indicated that the aptamer was folded into a pseudoknot structure, and some loop regions of the pseudoknot were located at the binding interface for the Raf-1 RBD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11856330     DOI: 10.1046/j.0014-2956.2001.02703.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  11 in total

1.  In vitro selection of ribozymes dependent on peptides for activity.

Authors:  Michael P Robertson; Scott M Knudsen; Andrew D Ellington
Journal:  RNA       Date:  2004-01       Impact factor: 4.942

2.  Translating Nanomedicine to Comparative Oncology-the Case for Combining Zinc Oxide Nanomaterials with Nucleic Acid Therapeutic and Protein Delivery for Treating Metastatic Cancer.

Authors:  R K DeLong; Yi-Hsien Cheng; Paige Pearson; Zhoumeng Lin; Calli Coffee; Elza Neelima Mathew; Amanda Hoffman; Raelene M Wouda; Mary Lynn Higginbotham
Journal:  J Pharmacol Exp Ther       Date:  2019-04-30       Impact factor: 4.030

Review 3.  In vivo imaging with oligonucleotides for diagnosis and drug development.

Authors:  B Tavitian
Journal:  Gut       Date:  2003-06       Impact factor: 23.059

4.  Inhibitors of Ras/Raf-1 interaction identified by two-hybrid screening revert Ras-dependent transformation phenotypes in human cancer cells.

Authors:  Juran Kato-Stankiewicz; Irina Hakimi; Gang Zhi; Jie Zhang; Ilya Serebriiskii; Lea Guo; Hironori Edamatsu; Hiroshi Koide; Sanjay Menon; Robert Eckl; Sukumar Sakamuri; Yingchun Lu; Quin-Zene Chen; Seema Agarwal; William R Baumbach; Erica A Golemis; Fuyuhiko Tamanoi; Vladimir Khazak
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-21       Impact factor: 11.205

5.  Development of novel single-stranded nucleic acid aptamers against the pro-angiogenic and metastatic enzyme heparanase (HPSE1).

Authors:  Suzanne C Simmons; Edward A McKenzie; Lynda K Harris; John D Aplin; Paul E Brenchley; Maria N Velasco-Garcia; Sotiris Missailidis
Journal:  PLoS One       Date:  2012-06-15       Impact factor: 3.240

6.  Site-specific biotinylation of RNA molecules by transcription using unnatural base pairs.

Authors:  Kei Moriyama; Michiko Kimoto; Tsuneo Mitsui; Shigeyuki Yokoyama; Ichiro Hirao
Journal:  Nucleic Acids Res       Date:  2005-08-19       Impact factor: 16.971

7.  Local neutral networks help maintain inaccurately replicating ribozymes.

Authors:  András Szilágyi; Ádám Kun; Eörs Szathmáry
Journal:  PLoS One       Date:  2014-10-09       Impact factor: 3.240

Review 8.  Unnatural base pair systems toward the expansion of the genetic alphabet in the central dogma.

Authors:  Ichiro Hirao; Michiko Kimoto
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2012       Impact factor: 3.493

9.  Development of a High-throughput NanoBRET Screening Platform to Identify Modulators of the RAS/RAF Interaction.

Authors:  David E Durrant; Emily A Smith; Ekaterina I Goncharova; Nirmala Sharma; Patrick A Alexander; Andrew G Stephen; Curtis J Henrich; Deborah K Morrison
Journal:  Mol Cancer Ther       Date:  2021-06-22       Impact factor: 6.009

10.  DNA aptamers against exon v10 of CD44 inhibit breast cancer cell migration.

Authors:  Joji Iida; Rebecca Clancy; Jesse Dorchak; Richard I Somiari; Stella Somiari; Mary Lou Cutler; Richard J Mural; Craig D Shriver
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.